Gruber James R.'s Form 4 filing
Eton Pharmaceuticals, Inc. (ETON) · filed Aug 20, 2025
- Accession no.
- 0001437749-25-027464
- Filed
- Aug 20, 2025
- Trade date
- Aug 19-20, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $673.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gruber James R.CIK 0001923165 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | Common Stock | SSaleDisposed | −39,082 | $16.16 | −$631,565.12 | 205,299 | Direct | |
| Aug 20, 2025 | Common Stock | SSaleDisposed | −2,631 | $16.02 | −$42,148.62 | 204,753 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.